Despite significant advancements in treatment, multiple myeloma remains an incurable disease, and nearly all patients experience relapse, often requiring increasingly complex therapeutic strategies.
With the rapid expansion of treatment options, particularly novel targeted therapies such as GPRC5D-directed approaches, the landscape of relapsed/refractory multiple myeloma (RRMM) management is evolving at an unprecedented pace. While these agents offer deep and durable remissions, their integration into clinical practice presents challenges in sequencing, toxicity management, and multidisciplinary coordination.
This educational initiative is designed to empower clinicians with the latest insights on GPRC5D-targeted therapies, facilitate the exchange of real-world clinical experience, and provide actionable strategies for optimizing patient outcomes. Through interactive discussions and expert-led guidance, participants will gain practical knowledge to navigate the complexities of RRMM treatment while fostering collaborative networks to enhance long-term patient care.
Join us to stay at the forefront of innovation in multiple myeloma management and elevate your clinical practice.
CME/CE Accreditation Information
This interactive program equips neurology providers with practical strategies to improve care for patients with myasthenia gravis. Grounded in real-world clinical challenges, the content focuses on early identification of high-risk patients, individualized treatment planning, and effective integration of newly approved and emerging therapies. Participants will gain insights that can be immediately applied to enhance outcomes across the spectrum of myasthenia gravis severity.
CME/CE Accreditation Information
This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.
CME/CE Accreditation Information
This curriculum examines the latest advancements in antibody-drug conjugate (ADC) therapy for metastatic triple-negative breast cancer (mTNBC) and HER2-low (HR+/HER2-) breast cancer. It provides insights into mechanisms of action, emerging clinical data, and strategies for integrating ADCs into treatment regimens to improve patient outcomes. Expert-led discussions and case-based learning will support clinicians in individualizing therapy and addressing real-world challenges in ADC use.
CME/CE Accreditation Information
This online program on idiopathic hypersomnia provides healthcare professionals with an in-depth understanding of this complex sleep disorder, including its pathophysiology, diagnosis, and management strategies. Through expert-led presentations and case-based discussions, participants will gain practical insights to improve patient outcomes in clinical practice.
CME/CE Accreditation Information
This curriculum is designed to empower neurologists, epileptologists, and pediatricians with the knowledge to address the unique challenges posed by Developmental and Epileptic Encephalopathies (DEEs). Through a blend of self-study modules, live discussions, and action planning, participants will learn to optimize care for DEE patients by understanding the impact of anti-seizure medications on both seizure and non-seizure symptoms.
CME/CE Accreditation Information
This dynamic course focuses on the exchange of best practices regarding the use of bispecifics in patients with R/R DLBCL including patient eligibility. Through this interactive, small-group activity, participants will review brief modules and patient cases to identify signs and symptoms of toxicities experienced while receiving treatment with bispecific antibodies for R/R DLBCL and also integrate protocols to manage CRS and ICANS effectively when managing patients. The group will gather for a live discussion via Zoom to share and exchange ideas on this topic.
CME/CE Accreditation Information
This curriculum on Comprehensive Approaches to Addressing Atopic Dermatitis in Very Young Patients is designed to equip healthcare professionals with a thorough understanding of effective strategies for managing and treating atopic dermatitis in infants and toddlers. This program integrates the latest medical research and practical insights to ensure participants gain comprehensive knowledge and skills necessary to provide optimal care for this vulnerable patient population.
CME/CE Accreditation Information
This small group educational experience is designed for clinicians involved in the management of Eosinophilic Esophagitis (EoE). It aims to deepen knowledge of EoE by exploring current treatment modalities, disease characteristics, and therapeutic outcomes. This program will also delve into evolving treatment paradigms and the significance of diagnostic imaging in the context of EoE management.
CME/CE Accreditation Information
